Background {#Sec1}
==========

Kikuchi-Fujimoto disease (KFD) or necrotizing histiocytic lymphadenitis, was described separately by both Kikuchi and Fujimoto in Japan in the early 1970's \[[@CR1], [@CR2]\]. Despite its rarity in the pediatric population, it is an important differential in persistent lymphadenopathy. KFD occurs predominantly in young women with associated symptoms of fever, lethargy, arthralgia and rash. Although the current etiology of KFD is unclear, associations have been made with autoimmune disease; with various infectious triggers including several viruses and other non-infective inflammatory conditions suggested. Familial cases of KFD in the literature are rare. Here we describe the first reported case of KFD in non-identical twin sisters.

Case presentation {#Sec2}
=================

Twin 1 {#Sec3}
------

Twin 1 presented at the age of 12 years in 2015. She had had an unremarkable medical history although there was significant family history which is outlined in our second case. The family were of Lebanese descent. She presented with a 3-week history of worsening right-sided cervical lymphadenopathy, daily fevers, significant lethargy, weight loss and arthralgia of her knees and ankles. On examination, she had firm enlarged lymph nodes in the submandibular, posterior chain and supraclavicular regions predominantly on the right but also on the left side of her neck. There was no overlying erythema or cutaneous change noted. There was also no significant joint swelling or effusion.

She was initially treated with intravenous antibiotics with little improvement. A biopsy of her right sided lymph nodes was undertaken and showed histiocytic necrosis consistent with KFD. Her fevers resolved during her hospital admission although her lymphadenopathy persisted. A day prior to her discharge from hospital she developed an erythematous maculopapular rash over her face, back and limbs.

Over the following months, she developed alopecia areata, arthralgia and oral ulceration with persistent and severe fatigue. Her rash subsided without intervention. She was trialed on a short course of oral steroids and her symptoms slowly resolved. Twin 1 after 2 years of follow-up showed no serological evidence of Systemic Lupus Erythematosus or other autoimmune disease and was well and attending school.

Twin 2 {#Sec4}
------

The second twin presented at 16 years of age in 2018. She had a history of frequently relapsing nephrotic syndrome from the age of 4. She required treatment with corticosteroids until the age of 12 along with other immunosuppressive medications including Cyclosporin, Tacrolimus and Mycophenolate Mofetil. She was subsequently commenced on intermittent Rituximab infusions leading to remission and prior to presentation with her lymphadenopathy had been in remission for more than 2 years. Complications of her treatment included steroid-induced osteoporosis which required intermittent intravenous bisphosphonate therapy. She had also been diagnosed with celiac disease treated with a gluten-free diet and was noted to be a CYP2C19 intermediate metaboliser.

She presented with a three-week history of lethargy, fatigue, weight loss and left-sided posterior cervical chain lymphadenopathy. Fever commenced 2 days prior to her presentation with associated night sweats and a 2-day history of coryzal symptoms. On examination, she had extensive lymphadenopathy of her left posterior cervical chain with no rash, joint changes or hepatosplenomegaly.

She was initially commenced on intravenous antibiotics. Her serology was positive for Mycoplasma and her nasopharyngeal aspirate was PCR positive for Respiratory Syncitiovirus. A biopsy of her lymph nodes was undertaken and showed histiocytic necrosis consistent with KFD.

After a one-week admission, she was discharged when her fevers had resolved. She subsequently developed arthralgia and a rash similarly to her sister but had no serological evidence of SLE. She was commenced on a course of oral steroids with subsequent improvement in her symptoms over time.

Investigations {#Sec5}
--------------

Both twins were comprehensively investigated with serological and biochemical testing as well as imaging, lymph node biopsy and tissue typing (Table [1](#Tab1){ref-type="table"}). The twins were HLA identical on examination of 8 HLA loci. Histology from Twin 2's biopsy is shown in Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}. They demonstrate loss of the lymph node's regular follicular architecture and areas of nonsuppurative necrosis. There is also a population of abnormal epithelioid cells which are positive for T-cell and histiocyte markers and negative for B cell markers. These are proliferating blastic T-cells that are found in Kikuchi-Fujimoto disease. Table 1Investigation Results for Twin 1 and Twin 2TestTwin 1Twin 2Normal RangeFull Blood CountHaemoglobin106 (L)104 (L)115--150 g/LWhite cell count3.4 (L)3.6 (L)4.5--13.5 × 10\^9/LPlatelet count199262150--600 × 10\^9/LNeutrophil count1.51.91.5--8.0 × 10\^9/LLymphocyte count1.51.41.0--4.0 × 10\^9/LLiver Function TestWithin normal limitsWithin normal limitsElectrolytes/Urea/CreatinineWithin normal limitsWithin normal limitsC-reactive Protein60 (H)82.2 (H)0--10 mg/LErythrocyte Sedimentation Rate101 (H)50 (H)0--20 mm/hrANA screenNegativeNegativeENA screenNot detectedNot detectedAnti-dsDNA antibodiesNegativeNegativeComplement C31.681.430.75--1.75 g/LComplement C40.340.320.13--0.52 g/LUrate0.240.300.14--0.36 mmol/LLactate Dehydrogenase586266 (L)313--618 U/LImmunoglobulinsIgGN/A4.33 (L)6.24--14.40 g/LIgAN/A\< 0.06 (L)0.59--3.96IgMN/A0.730.48--3.04IgEN/A\< 200--200 IU/mLToxoplasma serologyIgM/IgG negativeIgM/IgG negativeEBV serologyIgM/IgG negativeIgM/IgG negativeOther Infective serologyNilMycoplasma IgM positive, RSV PCR positiveHistopathologyHistiocytic necrosis, no bacteria on gram stain, no AFB on ZN, no fungal elements on PASHistiocytic necrosis, no bacteria on gram stain, no AFB on ZN, no fungal elements on PAS, flow cytometry showed no abnormal cell populationImagingCT: Extensive cervical lymphadenopathy with no other focusUltrasound: Multiple enlarged lymph nodes in the left cervical chain with increased vascularity, largest measures 20 × 13 mmHLA Class IA02:01, 03:0202:01, 03:02B08:01, 35:0808:01, 35:08C04:01, 07:0204:01, 07:02HLA Class IIDRB103:01, 07:0103:01, 07:01DRB302:0202:02DRB401:0301:03DPB104:01, 23:0104:01, 23:01DQB102:01, 02:0202:01, 02:02Fig. 1Histopathology slides taken from a lymph node biopsy of Twin 2. Stained with Haematoxylin and Eosin with magnification as noted in the images. **a** -- Loss of the normal follicular architecture of the lymph node with an area of abnormal cellularity in the subcapsular area. **b** -- Abrupt coagulative necrosis with no neutrophils ("sterile" necrosis). **c** -- Epithelioid cells with abnormal morphology which are the cells of origin for the coagulative necrosisFig. 2Histopathology slides taken from a lymph node biopsy of Twin 2 with immunohistochemical staining for various cell surface markers. **a** -- Positive staining for MUM1 (general lymphocyte activation marker). **b** -- Positive staining for CD4 (T-cell marker). **c** -- Positive staining for CD68 (histiocyte marker). **d** -- Negative staining for CD20 (B-cell marker). This shows the abnormal population of epithelioid cells which are positive for T-cell and hystiocyte markers and negative for B-cell markers and thus are the blastic T-cells that proliferate in Kikuchi-Fujimoto disease

Discussion {#Sec6}
==========

Kikuchi-Fujimoto disease remains more of a syndrome than a fully characterized disease. Twin 2 had nephrotic syndrome, a disease in which there is HLA linkage and evidence of viral activation similar to KFD \[[@CR3]\]. The presence of mycoplasma with positive mycoplasma serology at the time of diagnosis in Twin 2 would be consistent with an infectious trigger for KFD \[[@CR4]\].

Although very limited in number, there have been previous case reports documenting familial cases of KFD in siblings and even HLA-identical non-twin sisters \[[@CR5]--[@CR7]\]. Some of these familial cases have been documented in Japanese literature where related individuals who developed KFD were living in the same environment, were serologically positive for the same infectious trigger and had developed symptoms within a short time period of each other. Exceptions to this include the case report by Amir et al. (2002) in Saudi Arabia where two sisters who were HLA-identical but not twins had presented 10 years apart with no obvious infectious trigger identified and the article by Stasiuk et al. (2011) which reported a similar case in two Aboriginal sisters from Northern Ontario \[[@CR5], [@CR6]\]. The shared and common HLA for this disease suggests that like many other HLA-linked diseases, KFD is a two-step disease requiring a predisposing HLA and a secondary trigger such as an infection. Twin 2's background is particularly interesting as she has two other diseases that are linked to HLA Class II with celiac disease and nephrotic syndrome. This would be consistent with the paradigm that KFD needs an infectious trigger to develop but requires a specific HLA to develop disease. Although multiple offenders have been identified including Epstein Barr Virus, various Human Herpes Viruses, HIV, Torque Teno virus and Toxoplasma Gondii, it remains largely unclear if these pathogens are etiological or more likely inflammatory drivers of disease through TLR or other innate receptors \[[@CR4], [@CR8]--[@CR10]\].

Of note, the HLA typing of the sets of siblings described in Stasiuk et al. and Amir et al.'s case reports are shown in Table [2](#Tab2){ref-type="table"} \[[@CR5], [@CR6]\]. Interestingly, our twins' HLA-C type was identical to the siblings reported by Amir et al.^6^. Although the significance of this is unclear, this further supports the hypothesis regarding the etiology of KFD that we have put forward in this report. Table 2Comparison of HLA-Typing in Siblings with Kikuchi-Fujimoto DiseaseTwin 1Twin 2Sibling 1 (Stasiuk et al)^5^Sibling 2 (Stasiuk et al)^5^Sibling 1\
(Amir et al)^6^Sibling 2\
(Amir et al)^6^HLA Class IA02:01, 03:0202:01, 03:020202, 313131B08:01, 35:0808:01, 35:0839, 3539, 5135, 4935, 49C04:01, 07:0204:01, 07:0204, 0704, 07BW04, 0604, 06Cw07, 0407, 15HLA Class IIDRB103:01, 07:0103:01, 07:0108, 1408, 14DRB302:0202:02DRB401:0301:03DPB104:01, 23:0104:01, 23:01DR15, 1315, 13DRW51, 5251, 52DQ0606DQA102:01, 05.0102:01, 05.01DQB102:01, 02.0202:01, 02.020303, 0402

There have been many associations with KFD and other diseases in various case reports in the literature including but not exclusive to hemolytic uremic syndrome, Hashimoto's thyroiditis, hemophagocytic lymphohistiocytosis and more commonly, systemic lupus erythematosus \[[@CR11]--[@CR15]\]. Twin 2 had a background of nephrotic syndrome and celiac disease as discussed above. Both twins developed mucocutaneous symptoms that led to investigation for SLE but yielded no positive results. Although unclear, these associations with autoimmune conditions should guide clinicians when monitoring patients with prior KFD particularly in the context of disease surveillance or in the presence of new symptoms.

Interestingly, Twin 2 was serologically positive for *Mycoplasma pneumoniae* of which an association with KFD has not previously been documented. Although this could be coincidental, it should be noted that both Mycoplasma and KFD can lead to clinical signs and symptoms that may mimic other conditions or cause atypical presentations.

Conclusion {#Sec7}
==========

KFD is a rare but self-limiting pathological process of necrotizing histiocytic lymphadenitis. Although further research is needed, there is an increasing amount of evidence which suggests a multifactorial pathological basis of disease. The two cases we document here are the first reported cases of familial KFD in dizygotic HLA-identical twins which reinforces the likely HLA-linkage in the etiology of KFD. Due to its ability to mimic other more sinister illnesses, recognition and appropriate diagnosis of KFD is paramount to ensure that unnecessary investigations and treatment are avoided.
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